Page last updated: 2024-09-04

cyc 202 and sapropterin

cyc 202 has been researched along with sapropterin in 1 studies

Compound Research Comparison

Studies (cyc 202)	Trials (cyc 202)	Recent Studies (post-2010) (cyc 202)	Studies (sapropterin)	Trials (sapropterin)	Recent Studies (post-2010) (sapropterin)
979	7	393	2,362	93	614

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
An, J; Du, J; Guan, T; Pritchard, KA; Shi, Y; Wei, N; Xu, H	1

Other Studies

1 other study(ies) available for cyc 202 and sapropterin

Article	Year
Inhibition of CDKS by roscovitine suppressed LPS-induced NO production through inhibiting NFkappaB activation and BH4 biosynthesis in macrophages. American journal of physiology. Cell physiology, 2009, Volume: 297, Issue:3* Topics: Animals; Biopterins; Cell Line; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Gene Expression Regulation; GTP Cyclohydrolase; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Purines; Roscovitine	2009

Article

Year

Inhibition of CDKS by roscovitine suppressed LPS-induced *NO production through inhibiting NFkappaB activation and BH4 biosynthesis in macrophages.

American journal of physiology. Cell physiology, 2009, Volume: 297, Issue:3

Topics: Animals; Biopterins; Cell Line; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Gene Expression Regulation; GTP Cyclohydrolase; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Purines; Roscovitine

2009